4D MOLECULAR THERAPEUTICS IN's ticker is FDMT and the CUSIP is 35104E100. A total of 112 filers reported holding 4D MOLECULAR THERAPEUTICS IN in Q3 2023. The put-call ratio across all filers is 0.97 and the average weighting 0.1%.
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VR Adviser, LLC | 3,000,000 | $38,190,000 | 4.02% |
| Casdin Capital, LLC | 1,033,811 | $13,160,414 | 1.46% |
| BVF INC/IL | 4,007,413 | $51,014,367 | 1.38% |
| Deep Track Capital, LP | 2,778,107 | $35,365,302 | 1.36% |
| Opaleye Management Inc. | 308,500 | $3,927,205 | 1.28% |
| Eagle Health Investments LP | 437,911 | $5,574,607 | 1.23% |
| Novo Holdings A/S | 1,200,000 | $15,276,000 | 1.13% |
| RA Capital Management | 4,163,211 | $52,997,676 | 1.04% |
| VIKING GLOBAL INVESTORS LP | 4,787,914 | $60,950,145 | 0.25% |
| HighVista Strategies LLC | 33,419 | $425,424 | 0.20% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 650,000 | $8,274,500 | 0.18% |
| ArrowMark Colorado Holdings LLC | 1,084,721 | $13,808,498 | 0.17% |
| Peloton Wealth Strategists | 25,000 | $318 | 0.15% |
| Soleus Capital Management, L.P. | 123,748 | $1,575,312 | 0.14% |
| Privium Fund Management B.V. | 33,680 | $428,746 | 0.13% |
| Perigon Wealth Management, LLC | 246,150 | $3,133,490 | 0.13% |
| Elmwood Wealth Management, Inc. | 19,800 | $252,054 | 0.12% |
| GMT CAPITAL CORP | 151,200 | $1,924,776 | 0.07% |
| FOX RUN MANAGEMENT, L.L.C. | 12,162 | $154,822 | 0.05% |
| AIGEN INVESTMENT MANAGEMENT, LP | 16,985 | $216,219 | 0.04% |
External links
This page lists 4D MOLECULAR THERAPEUTICS IN's shareholders in Q3 2023. To view 4D MOLECULAR THERAPEUTICS IN's shareholder history, click here.